Table 3 Treatment results by systemic chemotherapy and chemoradiotherapy
No. | Sex | Age | Stage | PS | EGFR mutation status | Initial treatment | OR | PFS (mos) | OS (mos) | Outcome |
|---|---|---|---|---|---|---|---|---|---|---|
1 | M | 55 | Relapsed | 1 | Wild | DTX | PD | 0.7 | 7.3 | Died |
2 | F | 69 | Relapsed | 1 | Exon 19 del | Gefitinib | CR | 35.1 | 53.9 | Died |
3 | M | 60 | Relapsed | 1 | Wild | CBDCA + PTX | PD | 0.9 | 3.7 | Died |
4 | F | 45 | Relapsed | 0 | Wild | Gefitinib | PD | 1.7 | 10.7 | Died |
5 | M | 63 | Relapsed | 1 | Wild | CBDCA + PTX | PD | 0.6 | 12.7 | Died |
6 | M | 62 | Relapsed | 1 | Wild | CDDP + GEM | PD | 2.5 | 18.7 | Died |
7 | F | 53 | Relapsed | 2 | Wild | CBDCA + PTX | PD | 0.4 | 1 | Died |
8 | F | 55 | Relapsed | 1 | Wild | DTX | PD | 0.7 | 1.4 | Died |
9 | M | 56 | Advanced | 1 | NA | CBDCA + PTX | PD | 0.6 | 1.0 | Died |
10 | M | 77 | Advanced | 2 | Wild | CBDCA + ETP | PD | 1.5 | 7.2 | Died |
11 | M | 43 | Advanced | 1 | Wild | CBDCA + PTX | SD | 4.5 | 10.3 | Died |
12 | M | 62 | Advanced | 2 | Wild | CBDCA + PTX | NE | 0.4 | 0.4 | Died |
13 | M | 56 | Relapsed | 0 | Wild | CDDP + GEM | NE | 109.2 | 109.2 | Alive |
14 | M | 65 | Stage IIIA | 1 | Wild | CDDP + VNR + TRT | PR | 5.0 | 6.6 | Died |
15 | F | 66 | Relapsed | 1 | Exon 21 L858R | CDDP + VNR + TRT | PR | 3.9 | 6.9 | Died |
16 | F | 66 | Stage IIIA | 0 | NA | CDDP + VNR + TRT | PR | 65.4 | 65.4 | Alive |